Lord, Abbett & Co
RVMD icon

Lord, Abbett & Co’s Revolution Medicines RVMD Stock Holding History

Lord, Abbett & Co’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.1M Sell
134,233
-265,251
-66% -$26.8M 0.04% 327
2025
Q4 		$31.8M Buy
+399,484
New +$26.2M 0.1% 204
2025
Q2 		– Sell
-367,630
Closed -$13M – 576
2025
Q1 		$13M Sell
367,630
-1,611,090
-81% -$65.4M 0.05% 336
2024
Q4 		$86.5M Buy
1,978,720
+146,699
+8% +$7.4M 0.27% 101
2024
Q3 		$83.1M Buy
+1,832,021
New +$79.8M 0.26% 113
2020
Q3 		– Sell
-97,987
Closed -$3.09M – 675
2020
Q2 		$3.09M Sell
97,987
-52,807
-35% -$1.66M 0.01% 603
2020
Q1 		$3.3M Buy
+150,794
New +$4.17M 0.01% 576

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return